// App-Quantinova.ai

OC05.08 : Prenatal screening and testing for 45,X: lessons learned from 18,299 cfDNA results from the SMART study

Researchers

Presenter

  • K. Martin

Principal Investigators

  • R. Clifton

  • B. Jacobsson

  • S. Haeri

  • M. Egbert

  • F.D. Malone

  • R.J. Wapner

  • A. Roman

  • A. Khalil

  • R. Faro

  • R. Madankumar

  • L. Edwards

  • N. Strong

  • R. Silver

  • N. Vohra

  • J. Hyett

  • P. Billings

  • C. Kao

  • P. Dar

Medical Centers

  • Obstetrics and Gynecology, Long Island Jewish Medical Center, New Hyde Park, NY, USA

  • University of Utah Health Hospital, Salt Lake City, UT, USA

  • University of London, London, United Kingdom

  • Austin Maternal-Fetal Medicine, Austin, TX, USA

  • North Shore University Health System, Evanston, IL, USA

  • Royal College of Surgeons in Ireland, Dublin, Republic of Ireland

  • Childrens Hospital of Philadelphia, Center for Applied Genomics, Philadelphia, PA, USA

  • Icahn School of Medicine at Mount Sinai, New York, NY

  • Women and Babies, Royal Prince Alfred Hospital, Camperdown, NSW, Australia

  • George Washington University, Washington, WA, USA

  • St Peter's University Hospital, New Brunswick, NJ, USA

  • Obstetrics and Gynecology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA

  • Sahlgrenska Universitetssjukhuset, Goteborg, Sweden

  • Columbia University, New York, NY

  • New York University, New York, NY

  • University of California, San Francisco, San Francisco, CA

  • Suffolk Obstetrics and Gynecology, Port Jefferson, NY, USA

Locations

  • United States

  • United Kingdom

  • Ireland

  • Australia

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved